Genomma Lab Internacional S.A.B. de C.V (LABB) - Total Assets

Latest as of December 2025: MX$23.83 Billion MXN ≈ $1.37 Billion USD

Based on the latest financial reports, Genomma Lab Internacional S.A.B. de C.V (LABB) holds total assets worth MX$23.83 Billion MXN (≈ $1.37 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Genomma Lab Internacional S.A.B. de C.V (LABB) net assets for net asset value and shareholders' equity analysis.

Genomma Lab Internacional S.A.B. de C.V - Total Assets Trend (2005–2025)

This chart illustrates how Genomma Lab Internacional S.A.B. de C.V's total assets have evolved over time, based on quarterly financial data.

Genomma Lab Internacional S.A.B. de C.V - Asset Composition Analysis

Current Asset Composition (December 2025)

Genomma Lab Internacional S.A.B. de C.V's total assets of MX$23.83 Billion consist of 53.9% current assets and 46.1% non-current assets.

Asset Category	Amount (MXN)	% of Total Assets
Cash & Equivalents	MX$0.00	12.9%
Accounts Receivable	MX$4.50 Billion	18.9%
Inventory	MX$1.84 Billion	7.7%
Property, Plant & Equipment	MX$0.00	0.0%
Intangible Assets	MX$5.53 Billion	23.2%
Goodwill	MX$0.00	0.0%

Asset Composition Trend (2005–2025)

This chart illustrates how Genomma Lab Internacional S.A.B. de C.V's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see LABB market cap overview.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Genomma Lab Internacional S.A.B. de C.V's current assets represent 53.9% of total assets in 2025, an increase from 0.0% in 2005.
Cash Position: Cash and equivalents constituted 12.9% of total assets in 2025, down from 17.2% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 23.0% of total assets, an increase from 1.0% in 2005.
Asset Diversification: The largest asset category is intangible assets at 23.2% of total assets.

Genomma Lab Internacional S.A.B. de C.V Competitors by Total Assets

Key competitors of Genomma Lab Internacional S.A.B. de C.V based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Zhejiang Huahai Pharmaceutical Co Ltd SHG:600521	China	CN¥21.15 Billion
Emcure Pharmaceuticals Ltd NSE:EMCURE	India	Rs93.93 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	China	CN¥5.17 Billion
Ningbo Menovo Pharm Co Ltd SHG:603538	China	CN¥4.75 Billion
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr67.43 Billion
Changzhou Qianhong Biopharma Co Ltd SHE:002550	China	CN¥3.02 Billion

Genomma Lab Internacional S.A.B. de C.V - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.77	1.85	1.82
Quick Ratio	1.52	1.51	1.51
Cash Ratio	0.00	0.00	0.00
Working Capital	MX$5.61 Billion	MX$5.53 Billion	MX$5.42 Billion

Genomma Lab Internacional S.A.B. de C.V - Advanced Valuation Insights

This section examines the relationship between Genomma Lab Internacional S.A.B. de C.V's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.64
Latest Market Cap to Assets Ratio	0.04
Asset Growth Rate (YoY)	-1.0%
Total Assets	MX$23.83 Billion
Market Capitalization	$939.27 Million USD

Valuation Analysis

Below Book Valuation: The market values Genomma Lab Internacional S.A.B. de C.V's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Genomma Lab Internacional S.A.B. de C.V's assets decreased by 1.0% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Genomma Lab Internacional S.A.B. de C.V (2005–2025)

The table below shows the annual total assets of Genomma Lab Internacional S.A.B. de C.V from 2005 to 2025.

Year	Total Assets	Change
2025-12-31	MX$23.83 Billion ≈ $1.37 Billion	-1.03%
2024-12-31	MX$24.08 Billion ≈ $1.39 Billion	+16.36%
2023-12-31	MX$20.70 Billion ≈ $1.19 Billion	-4.21%
2022-12-31	MX$21.61 Billion ≈ $1.24 Billion	+0.30%
2021-12-31	MX$21.54 Billion ≈ $1.24 Billion	-2.66%
2020-12-31	MX$22.13 Billion ≈ $1.27 Billion	+14.95%
2019-12-31	MX$19.25 Billion ≈ $1.11 Billion	+6.51%
2018-12-31	MX$18.08 Billion ≈ $1.04 Billion	+13.80%
2017-12-31	MX$15.89 Billion ≈ $914.23 Million	+1.13%
2016-12-31	MX$15.71 Billion ≈ $904.04 Million	-10.91%
2015-12-31	MX$17.63 Billion ≈ $1.01 Billion	-30.66%
2014-12-31	MX$25.43 Billion ≈ $1.46 Billion	+46.54%
2013-12-31	MX$17.35 Billion ≈ $998.66 Million	+33.56%
2012-12-31	MX$12.99 Billion ≈ $747.73 Million	+41.32%
2011-12-31	MX$9.19 Billion ≈ $529.12 Million	+57.68%
2010-12-31	MX$5.83 Billion ≈ $335.57 Million	+37.47%
2009-12-31	MX$4.24 Billion ≈ $244.11 Million	+49.36%
2008-12-31	MX$2.84 Billion ≈ $163.44 Million	+137.84%
2007-12-31	MX$1.19 Billion ≈ $68.72 Million	+62.54%
2006-12-31	MX$734.61 Million ≈ $42.28 Million	+54.43%
2005-12-31	MX$475.69 Million ≈ $27.38 Million	--

About Genomma Lab Internacional S.A.B. de C.V

MX:LABB Mexico Drug Manufacturers - Specialty & Generic

Market Cap

$939.27 Million

MX$16.32 Billion MXN

Market Cap Rank

#9441 Global

#88 in Mexico

Share Price

MX$16.76

Change (1 day)

+3.27%

52-Week Range

MX$16.01 - MX$23.20

All Time High

MX$28.88